$RAIN A Mantra For Oncology TrialsTrial failures can sometimes be opportune events for investors. After Rain Oncology Inc. (NASDAQ: RAIN)’s Mantra treatment for Liposarcoma presented with subpar trial results, RAIN stock plummeted to a new all-time low. However, this sell-off could be an overreaction by the market since RAIN still h
